Jade Biosciences, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | — | $161.9M | $28.1M |
| Jun 2022 | — | $151.1M | $27.5M |
| Sep 2022 | — | $139.1M | $22.4M |
| Dec 2022 | — | $126.7M | $22.4M |
| Mar 2023 | — | $113.1M | $26.6M |
| Jun 2023 | — | $141.9M | $60.9M |
| Sep 2023 | — | $125.7M | $32.2M |
| Dec 2023 | — | $109.5M | $23.5M |
| Mar 2024 | — | $90.9M | $9.1M |
| Jun 2024 | — | $1.0K | — |
| Jun 2024 | — | $-589.0K | $31.1M |
| Sep 2024 | — | $-16.9M | $31.1M |
| Dec 2024 | — | $-46.8M | $69.4M |
| Mar 2025 | — | $-83.5M | $44.2M |
| Jun 2025 | — | $201.6M | $220.9M |
| Sep 2025 | — | $179.3M | $50.1M |
| Dec 2025 | — | $332.5M | $88.4M |
| Mar 2026 | — | $296.5M | $55.1M |
| Jun 2026 | — | $439.9M | $107.3M |